Prab: CSV import

2025-02-13T03:53:05Z

CSV import

← Older revision		Revision as of 03:53, 13 February 2025
Line 1:		Line 1:
	'''Fudosteine''' is a [[mucolytic agent]] used in the treatment of [[~~respiratory diseases~~]] ~~associated with viscous~~ or ~~excessive mucus. It is a~~ [[~~thiol~~]] ~~derivative developed in [[Japan]] and~~ is ~~characterized by~~ its ~~unique [[mechanism~~ of ~~action]] which differs~~ from ~~other mucolytic agents~~.		== Fudosteine ==

			[[File:Fudosteine.svg\|thumb\|right\|Chemical structure of Fudosteine]]

			'''Fudosteine''' is a [[mucolytic agent]] used in the treatment of [[chronic obstructive pulmonary disease]] (COPD) and other respiratory conditions characterized by excessive or thickened [[mucus]] production. It is known for its ability to reduce the viscosity of mucus, thereby facilitating its clearance from the airways.

	== Mechanism of Action ==		== Mechanism of Action ==
	Fudosteine works by ~~increasing~~ the ~~levels~~ of [[~~cysteine~~]] ~~in the~~ [[~~bronchial epithelium~~]]~~, which in turn enhances~~ the production of ~~[[glutathione]]~~. ~~Glutathione is a potent [[~~antioxidant]] that ~~protects~~ the ~~lungs from damage caused by [[reactive oxygen species]]~~. ~~Fudosteine also inhibits the production of [[mucus glycoproteins]]~~, ~~reducing~~ the ~~viscosity~~ and ~~elasticity~~ of ~~mucus, thereby improving mucus clearance from the lungs~~.
			Fudosteine works by modulating the production and secretion of mucus in the respiratory tract. It acts on the [[goblet cells]] and [[submucosal glands]] to decrease the production of mucus. Additionally, it has antioxidant properties that help in reducing the oxidative stress in the respiratory tract, which is often elevated in conditions like COPD.

			== Pharmacokinetics ==

			After oral administration, fudosteine is absorbed in the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily through the kidneys. The pharmacokinetic profile of fudosteine allows for effective mucolytic action with a relatively low incidence of systemic side effects.

	== Clinical Uses ==		== Clinical Uses ==
	Fudosteine is primarily used in the ~~treatment~~ of [[~~chronic~~ obstructive pulmonary disease]] (COPD)~~. It has been shown to reduce the frequency of [[exacerbations]] in patients with COPD and improve their quality of life. It is also used in the management of~~ [[~~bronchial asthma~~]], [[~~bronchiectasis~~]], and ~~other respiratory diseases characterized by mucus hypersecretion~~.
			Fudosteine is primarily used in the management of chronic respiratory diseases such as:

			* [[Chronic obstructive pulmonary disease]] (COPD)
			* [[Chronic bronchitis]]
			* [[Asthma]]

			It is often prescribed to patients who experience difficulty in expectorating thick mucus, thereby improving their breathing and quality of life.

	== Side Effects ==		== Side Effects ==
	The most common side effects of fudosteine include [[gastrointestinal disorders]] such as [[nausea]], [[vomiting]], and [[abdominal pain]]. Other side effects may include [[rash]], [[urticaria]], and [[pruritus]].

	~~== Contraindications ==~~		Common side effects of fudosteine include:
	~~Fudosteine is contraindicated in patients with a known [[hypersensitivity]] to the drug or any~~ of ~~its components. It should be used with caution in patients with a history of [[peptic ulcer disease]] due to the potential for [[gastrointestinal bleeding]].~~

	~~== Pharmacokinetics ==~~		* [[Nausea]]
	~~Fudosteine is well absorbed after oral administration and reaches peak plasma concentrations within 1 to 2 hours. It is metabolized in the liver~~ and ~~excreted in the urine~~.		* [[Diarrhea]]
			* [[Headache]]

			These side effects are generally mild and resolve with continued use or dose adjustment.

	== ~~References~~ ==		== Related Pages ==
	* ''Fudosteine: A New Approach to the Treatment of Chronic Obstructive Pulmonary Disease''. Journal of Clinical Pharmacology.
	* ''Fudosteine, a novel mucolytic agent, reduces the frequency of COPD exacerbations''. Chest Journal.

	[[~~Category:Drugs~~]]		* [[Mucolytic agent]]
	[[~~Category:Respiratory system~~]]		* [[Chronic obstructive pulmonary disease]]
	[[~~Category:Pharmacology]]~~		* [[Asthma]]
	~~[[Category:Medicine~~]]

	~~{{medicine-stub}}~~		[[Category:Respiratory drugs]]
			[[Category:Mucolytics]]

Prab: CSV import

2024-03-11T00:08:19Z

CSV import

New page

'''Fudosteine''' is a [[mucolytic agent]] used in the treatment of [[respiratory diseases]] associated with viscous or excessive mucus. It is a [[thiol]] derivative developed in [[Japan]] and is characterized by its unique [[mechanism of action]] which differs from other mucolytic agents.

== Mechanism of Action ==
Fudosteine works by increasing the levels of [[cysteine]] in the [[bronchial epithelium]], which in turn enhances the production of [[glutathione]]. Glutathione is a potent [[antioxidant]] that protects the lungs from damage caused by [[reactive oxygen species]]. Fudosteine also inhibits the production of [[mucus glycoproteins]], reducing the viscosity and elasticity of mucus, thereby improving mucus clearance from the lungs.

== Clinical Uses ==
Fudosteine is primarily used in the treatment of [[chronic obstructive pulmonary disease]] (COPD). It has been shown to reduce the frequency of [[exacerbations]] in patients with COPD and improve their quality of life. It is also used in the management of [[bronchial asthma]], [[bronchiectasis]], and other respiratory diseases characterized by mucus hypersecretion.

== Side Effects ==
The most common side effects of fudosteine include [[gastrointestinal disorders]] such as [[nausea]], [[vomiting]], and [[abdominal pain]]. Other side effects may include [[rash]], [[urticaria]], and [[pruritus]].

== Contraindications ==
Fudosteine is contraindicated in patients with a known [[hypersensitivity]] to the drug or any of its components. It should be used with caution in patients with a history of [[peptic ulcer disease]] due to the potential for [[gastrointestinal bleeding]].

== Pharmacokinetics ==
Fudosteine is well absorbed after oral administration and reaches peak plasma concentrations within 1 to 2 hours. It is metabolized in the liver and excreted in the urine.

== References ==
* ''Fudosteine: A New Approach to the Treatment of Chronic Obstructive Pulmonary Disease''. Journal of Clinical Pharmacology.
* ''Fudosteine, a novel mucolytic agent, reduces the frequency of COPD exacerbations''. Chest Journal.

[[Category:Drugs]]
[[Category:Respiratory system]]
[[Category:Pharmacology]]
[[Category:Medicine]]

{{medicine-stub}}

Fudosteine - Revision history

Prab: CSV import

Prab: CSV import